Report cover image

Near-Patient Molecular Solutions Global Market Report 2025

Published Dec 16, 2025
Length 250 Pages
SKU # BRC20651581

Description

Near-Patient Molecular Solutions Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on near-patient molecular solutions market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase
  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.
Description:

Where is the largest and fastest growing market for near-patient molecular solutions ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The near-patient molecular solutions market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:
  • The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope

Markets Covered:1) By Product Type: Infectious Diseases Testing Kits; Urinalysis Testing Kits; Tumor Or Cancer Markers; Pregnancy And Fertility; Hematology Testing Kits; Glucose Monitoring Kits; Drugs-Of-Abuse Testing Kits; Coagulation Monitoring Kits; Cardiometabolic Monitoring Kits; Other Product Types

2) By Technology: Polymerase Chain Reaction (PCR)-Based; Genetic Sequencing-Based; Hybridization-Based; Microarray-Based

3) By End-User: Hospitals And Clinics; Ambulatory Care Centers; Research Laboratories; Home Care Settings; Other End-Users

Subsegments:

1) By Infectious Diseases Testing Kits: Hepatitis Testing Kits; Human Immunodeficiency Virus Testing Kits; Influenza Testing Kits; COVID-19 Testing Kits

2) By Urinalysis Testing Kits: Protein Testing Kits; Glucose Testing Kits; Ketone Testing Kits; Nitrite Testing Kits

3) By Tumor Or Cancer Markers: Prostate-Specific Antigen Testing Kits; Carcinoembryonic Antigen Testing Kits; Cancer Antigen 125 Testing Kits; Alpha-Fetoprotein Testing Kits

4) By Pregnancy And Fertility: Ovulation Testing Kits; Early Pregnancy Testing Kits; Digital Pregnancy Testing Kits; Home Fertility Monitoring Kits

5) By Hematology Testing Kits: Complete Blood Count Testing Kits; Hemoglobin Testing Kits; White Blood Cell Count Testing Kits; Platelet Count Testing Kits

6) By Glucose Monitoring Kits: Self-Monitoring Blood Glucose Kits; Continuous Glucose Monitoring Kits; Non-Invasive Glucose Testing Kits; Disposable Glucose Test Strips

7) By Drugs-Of-Abuse Testing Kits: Urine Drug Testing Kits; Saliva Drug Testing Kits; Hair Drug Testing Kits; Blood Drug Testing Kits

8) By Coagulation Monitoring Kits: Prothrombin Time Testing Kits; International Normalized Ratio Testing Kits; Activated Partial Thromboplastin Time Testing Kits; D-Dimer Testing Kits

9) By Cardiometabolic Monitoring Kits: Cholesterol Testing Kits; Triglyceride Testing Kits; Low-Density Lipoprotein Testing Kits; High-Density Lipoprotein Testing Kits

10) By Other Product Types: Allergy Testing Kits; Thyroid Function Testing Kits; Vitamin Deficiency Testing Kits; Liver Function Testing Kits

Companies Mentioned: Bosch Healthcare Solutions GmbH; Roche Holding AG; Thermo Fisher Scientific Inc.; Abbott Laboratories; Danaher Corporation; Siemens Healthineers AG; Hologic Inc.; bioMérieux SA; Sysmex Corporation; QuidelOrtho Corporation; QIAGEN NV; DiaSorin SpA; OraSure Technologies Inc.; Molbio Diagnostics Pvt Ltd; Cue Health Inc.; Biocartis Group NV; Vela Diagnostics Pte Ltd; Co-Diagnostics Inc.; Hyris Ltd; Genedrive plc.

Please Note: Report will be updated with the latest data and delivered to you within 3-5 working days of order.

Table of Contents

250 Pages
1. Executive Summary
2. Near-Patient Molecular Solutions Market Characteristics
3. Near-Patient Molecular Solutions Market Trends And Strategies
4. Near-Patient Molecular Solutions Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
4.1. Supply Chain Impact from Tariff War & Trade Protectionism
5. Global Near-Patient Molecular Solutions Growth Analysis And Strategic Analysis Framework
5.1. Global Near-Patient Molecular Solutions PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Near-Patient Molecular Solutions Market Growth Rate Analysis
5.4. Global Near-Patient Molecular Solutions Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Near-Patient Molecular Solutions Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Near-Patient Molecular Solutions Total Addressable Market (TAM)
6. Near-Patient Molecular Solutions Market Segmentation
6.1. Global Near-Patient Molecular Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Infectious Diseases Testing Kits
Urinalysis Testing Kits
Tumor Or Cancer Markers
Pregnancy And Fertility
Hematology Testing Kits
Glucose Monitoring Kits
Drugs-Of-Abuse Testing Kits
Coagulation Monitoring Kits
Cardiometabolic Monitoring Kits
Other Product Types
6.2. Global Near-Patient Molecular Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Polymerase Chain Reaction (PCR)-Based
Genetic Sequencing-Based
Hybridization-Based
Microarray-Based
6.3. Global Near-Patient Molecular Solutions Market, Segmentation By End‑User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals And Clinics
Ambulatory Care Centres
Research Laboratories
Home Care Settings
Other End-Users
6.4. Global Near-Patient Molecular Solutions Market, Sub-Segmentation Of Infectious Diseases Testing Kits, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hepatitis Testing Kits
Human Immunodeficiency Virus Testing Kits
Influenza Testing Kits
COVID-19 Testing Kits
6.5. Global Near-Patient Molecular Solutions Market, Sub-Segmentation Of Urinalysis Testing Kits, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Protein Testing Kits
Glucose Testing Kits
Ketone Testing Kits
Nitrite Testing Kits
6.6. Global Near-Patient Molecular Solutions Market, Sub-Segmentation Of Tumor Or Cancer Markers, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Prostate-Specific Antigen Testing Kits
Carcinoembryonic Antigen Testing Kits
Cancer Antigen 125 Testing Kits
Alpha-Fetoprotein Testing Kits
6.7. Global Near-Patient Molecular Solutions Market, Sub-Segmentation Of Pregnancy And Fertility, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Ovulation Testing Kits
Early Pregnancy Testing Kits
Digital Pregnancy Testing Kits
Home Fertility Monitoring Kits
6.8. Global Near-Patient Molecular Solutions Market, Sub-Segmentation Of Hematology Testing Kits, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Complete Blood Count Testing Kits
Hemoglobin Testing Kits
White Blood Cell Count Testing Kits
Platelet Count Testing Kits
6.9. Global Near-Patient Molecular Solutions Market, Sub-Segmentation Of Glucose Monitoring Kits, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Self-Monitoring Blood Glucose Kits
Continuous Glucose Monitoring Kits
Non-Invasive Glucose Testing Kits
Disposable Glucose Test Strips
6.10. Global Near-Patient Molecular Solutions Market, Sub-Segmentation Of Drugs-Of-Abuse Testing Kits, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Urine Drug Testing Kits
Saliva Drug Testing Kits
Hair Drug Testing Kits
Blood Drug Testing Kits
6.11. Global Near-Patient Molecular Solutions Market, Sub-Segmentation Of Coagulation Monitoring Kits, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Prothrombin Time Testing Kits
International Normalized Ratio Testing Kits
Activated Partial Thromboplastin Time Testing Kits
D-Dimer Testing Kits
6.12. Global Near-Patient Molecular Solutions Market, Sub-Segmentation Of Cardiometabolic Monitoring Kits, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Cholesterol Testing Kits
Triglyceride Testing Kits
Low-Density Lipoprotein Testing Kits
High-Density Lipoprotein Testing Kits
6.13. Global Near-Patient Molecular Solutions Market, Sub-Segmentation Of Other Product Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Allergy Testing Kits
Thyroid Function Testing Kits
Vitamin Deficiency Testing Kits
Liver Function Testing Kits
7. Near-Patient Molecular Solutions Market Regional And Country Analysis
7.1. Global Near-Patient Molecular Solutions Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Near-Patient Molecular Solutions Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Near-Patient Molecular Solutions Market
8.1. Asia-Pacific Near-Patient Molecular Solutions Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Near-Patient Molecular Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Near-Patient Molecular Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Near-Patient Molecular Solutions Market, Segmentation By End‑User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Near-Patient Molecular Solutions Market
9.1. China Near-Patient Molecular Solutions Market Overview
9.2. China Near-Patient Molecular Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Near-Patient Molecular Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Near-Patient Molecular Solutions Market, Segmentation By End‑User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Near-Patient Molecular Solutions Market
10.1. India Near-Patient Molecular Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Near-Patient Molecular Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Near-Patient Molecular Solutions Market, Segmentation By End‑User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Near-Patient Molecular Solutions Market
11.1. Japan Near-Patient Molecular Solutions Market Overview
11.2. Japan Near-Patient Molecular Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Near-Patient Molecular Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Near-Patient Molecular Solutions Market, Segmentation By End‑User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Near-Patient Molecular Solutions Market
12.1. Australia Near-Patient Molecular Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Near-Patient Molecular Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Near-Patient Molecular Solutions Market, Segmentation By End‑User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Near-Patient Molecular Solutions Market
13.1. Indonesia Near-Patient Molecular Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Near-Patient Molecular Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Near-Patient Molecular Solutions Market, Segmentation By End‑User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Near-Patient Molecular Solutions Market
14.1. South Korea Near-Patient Molecular Solutions Market Overview
14.2. South Korea Near-Patient Molecular Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Near-Patient Molecular Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Near-Patient Molecular Solutions Market, Segmentation By End‑User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Near-Patient Molecular Solutions Market
15.1. Western Europe Near-Patient Molecular Solutions Market Overview
15.2. Western Europe Near-Patient Molecular Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Near-Patient Molecular Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Near-Patient Molecular Solutions Market, Segmentation By End‑User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Near-Patient Molecular Solutions Market
16.1. UK Near-Patient Molecular Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Near-Patient Molecular Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Near-Patient Molecular Solutions Market, Segmentation By End‑User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Near-Patient Molecular Solutions Market
17.1. Germany Near-Patient Molecular Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Near-Patient Molecular Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Near-Patient Molecular Solutions Market, Segmentation By End‑User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Near-Patient Molecular Solutions Market
18.1. France Near-Patient Molecular Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Near-Patient Molecular Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Near-Patient Molecular Solutions Market, Segmentation By End‑User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Near-Patient Molecular Solutions Market
19.1. Italy Near-Patient Molecular Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Near-Patient Molecular Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Near-Patient Molecular Solutions Market, Segmentation By End‑User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Near-Patient Molecular Solutions Market
20.1. Spain Near-Patient Molecular Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Near-Patient Molecular Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Near-Patient Molecular Solutions Market, Segmentation By End‑User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Near-Patient Molecular Solutions Market
21.1. Eastern Europe Near-Patient Molecular Solutions Market Overview
21.2. Eastern Europe Near-Patient Molecular Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Near-Patient Molecular Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Near-Patient Molecular Solutions Market, Segmentation By End‑User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Near-Patient Molecular Solutions Market
22.1. Russia Near-Patient Molecular Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Near-Patient Molecular Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Near-Patient Molecular Solutions Market, Segmentation By End‑User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Near-Patient Molecular Solutions Market
23.1. North America Near-Patient Molecular Solutions Market Overview
23.2. North America Near-Patient Molecular Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Near-Patient Molecular Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Near-Patient Molecular Solutions Market, Segmentation By End‑User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Near-Patient Molecular Solutions Market
24.1. USA Near-Patient Molecular Solutions Market Overview
24.2. USA Near-Patient Molecular Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Near-Patient Molecular Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Near-Patient Molecular Solutions Market, Segmentation By End‑User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Near-Patient Molecular Solutions Market
25.1. Canada Near-Patient Molecular Solutions Market Overview
25.2. Canada Near-Patient Molecular Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Near-Patient Molecular Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Near-Patient Molecular Solutions Market, Segmentation By End‑User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Near-Patient Molecular Solutions Market
26.1. South America Near-Patient Molecular Solutions Market Overview
26.2. South America Near-Patient Molecular Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Near-Patient Molecular Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Near-Patient Molecular Solutions Market, Segmentation By End‑User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Near-Patient Molecular Solutions Market
27.1. Brazil Near-Patient Molecular Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Near-Patient Molecular Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Near-Patient Molecular Solutions Market, Segmentation By End‑User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Near-Patient Molecular Solutions Market
28.1. Middle East Near-Patient Molecular Solutions Market Overview
28.2. Middle East Near-Patient Molecular Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Near-Patient Molecular Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Near-Patient Molecular Solutions Market, Segmentation By End‑User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Near-Patient Molecular Solutions Market
29.1. Africa Near-Patient Molecular Solutions Market Overview
29.2. Africa Near-Patient Molecular Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Near-Patient Molecular Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Near-Patient Molecular Solutions Market, Segmentation By End‑User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Near-Patient Molecular Solutions Market Competitive Landscape And Company Profiles
30.1. Near-Patient Molecular Solutions Market Competitive Landscape
30.2. Near-Patient Molecular Solutions Market Company Profiles
30.2.1. Bosch Healthcare Solutions GmbH Overview, Products and Services, Strategy and Financial Analysis
30.2.2. Roche Holding AG Overview, Products and Services, Strategy and Financial Analysis
30.2.3. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
30.2.4. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
30.2.5. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
31. Near-Patient Molecular Solutions Market Other Major And Innovative Companies
31.1. Siemens Healthineers AG
31.2. Hologic Inc.
31.3. bioMérieux SA
31.4. Sysmex Corporation
31.5. QuidelOrtho Corporation
31.6. QIAGEN NV
31.7. DiaSorin SpA
31.8. OraSure Technologies Inc.
31.9. Molbio Diagnostics Pvt Ltd
31.10. Cue Health Inc.
31.11. Biocartis Group NV
31.12. Vela Diagnostics Pte Ltd
31.13. Co-Diagnostics Inc.
31.14. Hyris Ltd
31.15. Genedrive plc
32. Global Near-Patient Molecular Solutions Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The Near-Patient Molecular Solutions Market
34. Recent Developments In The Near-Patient Molecular Solutions Market
35. Near-Patient Molecular Solutions Market High Potential Countries, Segments and Strategies
35.1 Near-Patient Molecular Solutions Market In 2029 - Countries Offering Most New Opportunities
35.2 Near-Patient Molecular Solutions Market In 2029 - Segments Offering Most New Opportunities
35.3 Near-Patient Molecular Solutions Market In 2029 - Growth Strategies
35.3.1 Market Trend Based Strategies
35.3.2 Competitor Strategies
36. Appendix
36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer
How Do Licenses Work?
Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.